FdaApplication
BLA 761083
Identifiers
- fda_app_no: BLA761083
Properties
| Property | Value |
|---|---|
| applicant_name | Genentech, Inc. |
| application_type | BLA |
| approval_date | 2017-11-16 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HEMLIBRA | EMICIZUMAB | 60MG/0.4ML | Injection |
| HEMLIBRA | EMICIZUMAB | 105MG/0.7ML | Injection |
| HEMLIBRA | EMICIZUMAB | 30MG/ML | Injection |
| HEMLIBRA | EMICIZUMAB | 150MG/ML | Injection |
| HEMLIBRA | — | 300MG/2ML (150MG/ML) | Injection |
| HEMLIBRA | — | 12MG/0.4ML | Injection |
6 products